4-Nitrobenzyl 1-Thio-β-D-galactopryranoside
- CAS35785-19-4
- CatalogueRS-Z401I9U
- FormulaC13H17NO7S
- MW331.07
On this page
Product identification
| Product name | 4-Nitrobenzyl 1-Thio-β-D-galactopryranoside |
|---|---|
| Catalogue No. | RS-Z401I9U |
| CAS No. | 35785-19-4 |
| Molecular formula | C13H17NO7S |
| Molecular weight | 331.07 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | General Reference Standards |
| Drug substance | Metabolites |
| Also known as | CATO |
| Storage | 2–8 °C (refrigerated), protect from light |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z401I9U / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Metabolites
- General Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z401I9U
- Request a quotation for RS-Z401I9U
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Metabolites
All 112 further standards are listed here — every link is in the page, not loaded later.
-
(3β,5β,17α)-19-Norpregnane-3,17-diol
IN STOCKRS-Z401HWR -
(E/Z)-2-Propyl-2,4-pentadienoic Acid Methyl Ester
CUSTOM SYNTHESISRS-Z400SND -
(S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid, 97%
CUSTOM SYNTHESISRS-Z401HZV -
(±)-Disparlure
IN STOCKRS-Z401HFK -
1,2-Benzenedicarboxylic Acid Mono(carboxymethyl) Ester
IN STOCKRS-Z401HMF -
1-(2-Hydroxyethyl)lepidinium Bromide
IN STOCKRS-Z401GLJ -
1-(3-(4-Bromophenyl)-5-methylisoxazol-4-yl)ethanone
IN STOCKRS-Z401D04 -
1-(4-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxylic Acid
IN STOCKRS-Z401FP3 -
1-(4-Chloro-6,7-dimethoxyphthalazin-1-yl)piperidin-4-yl Ethylcarbamate
CUSTOM SYNTHESISRS-Z401CI4 -
1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
CUSTOM SYNTHESISRS-Z401I6F -
1-Hydroxy-3-methylanthraquinone
IN STOCKRS-Z401GEJ -
1-Phenyl-3-(phenylamino)pyrrolidine-2,5-dione
IN STOCKRS-Z401GQH -
10-Hydroxy Protriptyline
IN STOCKRS-Z401GUS -
17.alpha.-Pregn-5-en-20-yne-3.beta.,17.beta.-diol
IN STOCKRS-Z401IAT -
2',4'-Dinitrophenyl beta-D-galactopyranoside
IN STOCKRS-Z401GGF -
2,2-Dichloro-1,1-bis(4-chlorophenyl)ethanol
IN STOCKRS-Z401I9H -
2,3,4,5-Tetrabromobenzoic acid
BACK ORDERRS-Z401GWC -
2,3,4,5-Tetrahydro-1H-3-benzazepin-7-amine monohydrochloride
IN STOCKRS-Z401E2W -
2,4-Dichlorodibenzofuran
IN STOCKRS-Z401G5O -
2,4-Dinitrophenyl 2-Deoxy-2-fluoro-β-D-galactoside 3,4,6-Triacetate
BACK ORDERRS-Z401ETW -
2-((3-Hydroxy-2-methylpropoxy)carbonyl)benzoic acid
IN STOCKRS-Z400YA6 -
2-(2'-Pyridyl)-3-oxo-3H-indole N-Oxide
IN STOCKRS-Z401HAI -
2-(2-Hydroxyphenyl)oxirane
IN STOCKRS-Z401GAO -
2-(7-Carboxy-4-methylheptoxy)carbonylcyclohexane-1-carboxylic acid
IN STOCKRS-Z401CRF -
2-Amino-2-[2-[4-(8-hydroxyoctyl)phenyl]ethyl]propane-1,3-diol;hydrochloride
CUSTOM SYNTHESISRS-Z400SR2 -
2-Anthraceneacetic Acid 2,5-Dioxo-1-pyrrolidinyl Ester
IN STOCKRS-Z401DE3 -
2-Chloro-5-(1-methyl-2-pyrrolidinyl)pyridine
CUSTOM SYNTHESISRS-Z401DXA -
2-Chloro-7-hydroxy Phenothiazine
IN STOCKRS-Z401EJC -
2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynoic acid
IN STOCKRS-Z401DY3 -
2-Diazo-acetic Acid 1,1-Dimethylethyl Ester
IN STOCKRS-Z401I7U -
2-Methyl-5α-androst-2-en-17β-ol
IN STOCKRS-Z401HFW -
2-Methyl-5α-androst-2-en-17β-ol-propionate
IN STOCKRS-Z401HFV -
2-Nitro-3-methyl-9H-pyrido[2,3-b]indole
IN STOCKRS-Z401DYY -
2-Nitrophenyl β-D-xylobioside
BACK ORDERRS-Z401CGS -
2-O-(4-Nitrophenyl)-α-D-N-acetylneuraminic acid sodium salt
CUSTOM SYNTHESISRS-Z400OWX -
2-Thio 2-Deoxyuridine
IN STOCKRS-Z401I7T -
2-Thiothymidine
IN STOCKRS-Z401H52 -
3,24-Diepibrassinolide
BACK ORDERRS-Z401CR2 -
3,4-Dihydroxydecanoic Acid
IN STOCKRS-Z401CH0 -
3,4-Dihydroxyhippuric Acid
IN STOCKRS-Z401CUA -
3,6-Dichlorosalicylic Acid (Dcsa) (Ring-13c6, 99%)
IN STOCKRS-Z400K51 -
3-Aceto-2-hydroxybiphenyl
IN STOCKRS-Z401F59 -
3-Hydroxy-N-acetyl-2-aminofluorene
IN STOCKRS-Z401DUS -
3-Methyl-8-(2-deoxy-β-D-ribofuranosyl)isoxanthopterin
IN STOCKRS-Z401D11 -
3β-Hydroxy-5α-pregnan-20-one Sulfate Pyridine Salt
BACK ORDERRS-Z400P5G -
3β-Hydroxyandrosta-5,15-dien-17-one
IN STOCKRS-Z401DDN -
4,6-Diaminoquinazoline
CUSTOM SYNTHESISRS-Z401CIQ -
4-(Methylamino)-4-(3-pyridyl)butyric Acid
CUSTOM SYNTHESISRS-Z401465 -
4-(N-[2,4-DIAMINO-6-PTERIDINYLMETHYL]-AMINO)BENZOIC ACID SODIUM SALT
IN STOCKRS-Z400EUD -
4-Hydroxy Guanabenz Hydrochloride
IN STOCKRS-Z400S71 -
4-Hydroxy-L-threonine
CUSTOM SYNTHESISRS-Z401FA9 -
4-Methylumbelliferyl -β-D-Gentotrioside
CUSTOM SYNTHESISRS-Z401IGC -
4-Methylumbelliferyl 2-Acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-α-D-galactopyranoside
CUSTOM SYNTHESISRS-Z401F0E -
4-Methylumbelliferyl 2-Acetamido-2-deoxy-4-O-(α-L-fucopyranosyl)-β-D-glucopyranoside
BACK ORDERRS-Z401IGB -
4-Methylumbelliferyl 2-O-(α-L-Fucopyranosyl)-β-D-galactopyranoside
CUSTOM SYNTHESISRS-Z401FLV -
4-Nitrophenyl 2-Acetamido-2-deoxy-4-O-α-L-fucopyranosyl)-β-D-glucopyranoside
BACK ORDERRS-Z401GHJ -
4-Phenyl-2-imidazolidinone
IN STOCKRS-Z401GR5 -
4’-Hydroxy-PhIP-O-sulfate
IN STOCKRS-Z400ON9 -
5(4H)-Oxazolone, 4-((4-(acetyloxy)-3-methoxyphenyl)methylene)-2-methyl-
IN STOCKRS-Z401IIW -
5- Methoxy- 4- (phenylmethoxy) -1H- indole- 3- acetonitrile
IN STOCKRS-Z401G3T -
5-[(7-Chloro-4-quinolinyl)amino]-2-hydroxybenzaldehyde
IN STOCKRS-Z401D46 -
5-Hydroxy-PhIP
IN STOCKRS-Z401CIT -
5-hydroxyisoquinoline, tech., 90%
IN STOCKRS-Z401G4C -
5-Hydroxypyrazine-2-carboxylic Acid Methyl Ester
CUSTOM SYNTHESISRS-Z400V02 -
6-(4-Bromophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole
IN STOCKRS-Z401I87 -
6-Thioguanosine Triphosphate
BACK ORDERRS-Z401D9C -
7-Fluoro-2,3,4,5-tetrahydro-1H-3-benzazepine
IN STOCKRS-Z401HZC -
7-Octen-4-one, 2,6-dimethyl-
IN STOCKRS-Z401E0Q -
8-Hydroxy-1-nitropyrene
CUSTOM SYNTHESISRS-Z401D4X -
AB-CHMINACA metabolite M2
IN STOCKRS-Z400LRK -
AHD-HN
IN STOCKRS-Z400P8U -
Alclofenac Methyl Ester
IN STOCKRS-Z401FYS -
Amopyroquine N-Oxide
IN STOCKRS-Z401D45 -
AMOZ-HN
IN STOCKRS-Z400SSN -
Benzamide, 2-hydroxy-3-(1H-imidazol-4-ylmethyl)-N-methyl-, monohydrochloride
CUSTOM SYNTHESISRS-Z400QRK -
C2-Methyladenosine
IN STOCKRS-Z401CU9 -
Chromyl chloride
CUSTOM SYNTHESISRS-Z400YUN -
D-o-Tyrosine
IN STOCKRS-Z401FZF -
Ethyl 2-Chlorobenzo[d]thiazole-5-carboxylate
IN STOCKRS-Z401CXP -
Glyceric Acid 3-Phosphate Barium Salt
IN STOCKRS-Z401FKR -
Homo Egonol -β-D-Glucoside
BACK ORDERRS-Z401HZU -
InChI=1/C9H11NO3/c1-10-9(11)13-8-5-3-4-7(6-8)12-2/h3-6H,1-2H3,(H,10,11
CUSTOM SYNTHESISRS-Z401IIF -
Melarsen Oxide
IN STOCKRS-Z401FAU -
Mono(3-tetrahydropyranyloxybutyl)phthalate
IN STOCKRS-Z401DF3 -
Mono-(7-carboxy-2,7-dimethylheptyl) Phthalate
IN STOCKRS-Z400TWZ -
N-(2-Hydroxyethyl)tricosanamide
IN STOCKRS-Z401D2P -
N-(4-Methoxyphenyl)-N'-1,2,3-thiadiazol-5-yl-urea
IN STOCKRS-Z400TGO -
N-4-Piperidylacetanilide Hydrochloride
CUSTOM SYNTHESISRS-Z401FI2 -
N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-valinate
IN STOCKRS-Z401EFO -
N-Desethyl Sunitinib HemimalateDISCONTINUED
CUSTOM SYNTHESISRS-Z400YL2 -
N-Desmethyl (E)-α-Hydroxy Tamoxifen
IN STOCKRS-Z401CNP -
N-Desmethyl-3-hydroxy Tamoxifen O-β-D-Glucuronide
CUSTOM SYNTHESISRS-Z401ERW -
N-Methyl-N-2-propynylamine
CUSTOM SYNTHESISRS-Z401I85 -
N-SuccinimidylN-methylcarbamate
IN STOCKRS-Z401DTW -
N-Succinyl-5-aminoimidazole-4-carboxamide Ribose 5-Phosphate
BACK ORDERRS-Z401HKA -
S-(5-Nitro-2-benzyloxy)phenyl-N-tert-butyloxycarbonyl-L-cysteine
BACK ORDERRS-Z401DGA -
S-(5-Nitro-2-benzyloxy)phenyl-N-tert-butyloxycarbonyl-L-cysteine Methyl Ester
BACK ORDERRS-Z401DG8 -
Sodium 2-benzothiazolesulfonate
IN STOCKRS-Z401F5W -
α-Methylamino-1-hydroxy Valerophenone
IN STOCKRS-Z400WCO -
β-(Trifluoromethyl)phenylalanine
IN STOCKRS-Z400IIG -
β-2-Deoxy Zebularine
IN STOCKRS-Z401FC8 -
∆9(11)-Estradiol Diacetate
IN STOCKRS-Z400JES
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.
![Chemical structure of (3S,3aS,5aS,6R,9aS,9bS)-Dodecahydro-3-hydroxy-3a,6-dimethyl-7-oxo-1H-benz[e]indene-6-propanoic Acid](/structures/w4/COGRAKQBTBRYQC-HHJOSPGFSA-N.webp?v=7)









![Chemical structure of 1-[(3S,5S,6R,8R,9S,10R,13S,14S,17S)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone](/structures/w4/HHUZGDMRRLQZIQ-ISDOSQBDSA-N.webp?v=7)
![Chemical structure of 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione](/structures/w4/AEPOJXVSQUFPCK-UHFFFAOYSA-N.webp?v=7)













![Chemical structure of 2-(4-Aminophenyl)-1,2-dihydro-7-[(1-oxido-2-pyridinyl)methoxy]-1-oxo-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylic Acid methyl Ester MonoHCl](/structures/w4/ANSBEKVVFSMGLE-UHFFFAOYSA-N.webp?v=7)

![Chemical structure of 2-Amino-2-[2-[4-(8-hydroxyoctyl)phenyl]ethyl]propane-1,3-diol;hydrochloride](/structures/w4/OFOJNDCKDFZROS-UHFFFAOYSA-N.webp?v=7)







![Chemical structure of 2-Nitro-3-methyl-9H-pyrido[2,3-b]indole](/structures/w4/YETURKHPVJNYTO-UHFFFAOYSA-N.webp?v=7)









![Chemical structure of 3-(2-Deoxy-5-O-phosphono-β-D-erythro-pentofuranosyl)-3,4-dihydro-5H-imidazo[2,1-i]purine-5-thione](/structures/w4/VREPQHUJJVGJIT-RNJXMRFFSA-N.webp?v=7)





![Chemical structure of 4,5-Dihydro-2-[2-methyl-3-(1H-imidazol-5-ylmethyl)phenyl]-4,4-dimethyl-oxazole](/structures/w4/YZEWAXQSKIAOOD-UHFFFAOYSA-N.webp?v=7)


![Chemical structure of 4-(N-[2,4-DIAMINO-6-PTERIDINYLMETHYL]-AMINO)BENZOIC ACID SODIUM SALT](/structures/w4/NDXULQWYAMJQGC-UHFFFAOYSA-M.webp?v=7)







![Chemical structure of 4-Nitrophenyl 2-acetamido-2-deoxy-4-O-[2-O-(α-L-fucopyranosyl)-β-D-galactopyranosyl]-β-D-glucopyranoside](/structures/w4/NXLTWNKLPSVELR-UOFGCEEZSA-N.webp?v=7)





![Chemical structure of 5-[(7-Chloro-4-quinolinyl)amino]-2-hydroxybenzaldehyde](/structures/w4/AZKNHPGTHFOACE-UHFFFAOYSA-N.webp?v=7)



![Chemical structure of 6-(4-Bromophenyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole](/structures/w4/GPJBSEDJRPMPHS-UHFFFAOYSA-N.webp?v=7)













![Chemical structure of ditert-butyl [2,2-dimethyl-4-(6-sulfanylidene-3H-purin-9-yl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl phosphate](/structures/w4/QQFBRLIRKFVXGH-SCFUHWHPSA-N.webp?v=7)
![Chemical structure of Ethyl 2-Chlorobenzo[d]thiazole-5-carboxylate](/structures/w4/KCFAMALYDWEQDE-UHFFFAOYSA-N.webp?v=7)









![Chemical structure of N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-valinate](/structures/w4/CRGGXDSTBHQLKJ-UHFFFAOYSA-N.webp?v=7)













